193 In the index

Ipamorelin + CJC blend IPA/CJC

A combination pairing ipamorelin with CJC-1295, another growth-hormone-boosting peptide, meant to create a stronger combined effect. This claimed benefit comes from how each works on its own, not from any actual human study of the two together.

Also known as Blend

Effects Build muscle Heal

Routes Subcutaneous

Legal status Research chemical

WADA Banned at all times

Reported dosing

User-reported

What has been reported in the literature and by users. This is a record of what is done, not a recommendation.

Typical dose Ipamorelin 100-200 mcg + CJC-1295 100 mcg, combined

Reported range Varies by vendor protocol

Route Subcutaneous injection

Frequency 1-3 times daily, typically before bed and/or post-workout

Duration 8-12 week course (unregulated use)

A very common 'GH-boosting' peptide stack; the combination itself has not been studied in controlled human trials, and dosing comes entirely from vendor/forum sources.

Where this comes from User-reported/research-chemical vendor literature

There is no approved human dosing for this compound. The figures above are what users and vendors report, not what has been established as safe or effective. Treat them as a record of what is done, not as guidance.